Zehra Somjee

No ORCID on file · 1 paper in corpus
review 2021
·doi:10.1186/s43043-021-00064-5

Abstract Background Heavy menstrual bleeding (HMB) is a common clinical finding in patients with uterine leiomyomas that can negatively impact their quality of life. Recently, a novel oral GnRH-antagonist (elagolix) has emerged as a possibl…